-
ESTABLISHMENT OF THE IMPORTANCE OF AND MEANINGFUL CHANGE IN PHYSICAL ACTIVITY IN PATIENTS WITH CANCER CACHEXIA; A DHT-MEASURABLE CONCEPT
Aug 11, 2026, 17:16 PM -
SEASONAL BURDEN, REGIONAL VARIATION, AND HEALTH-SYSTEM SIGNALS IN IN-HOSPITAL PNEUMONIA MORTALITY
Aug 11, 2026, 17:16 PM -
INCLUSION OF ML-NMR RESULTS IN PROBABILISTIC SENSITIVITY ANALYSIS: BALANCING BIAS AND COMPUTATIONAL COST
Aug 11, 2026, 17:16 PM -
LONG-TERM EFFICACY OF NETAKIMAB IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS (R-AXSPA): SIMULATED TREATMENT COMPARISONS RESULTS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF APIXABAN VERSUS ACENOCOUMAROL FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN ALGERIA
Aug 11, 2026, 17:16 PM -
IS GENERIC SUBSTITUTION A POLICY BLUEPRINT FOR BIOSIMILAR SUBSTITUTION IN COMMUNITY PHARMACY?
Aug 11, 2026, 17:16 PM -
DOES PRIMARY ENDPOINT TYPE INFLUENCE REGULATORY AND HTA OUTCOMES FOR EMA APPROVED ONCOLOGY MEDICINES IN ITALY?
Aug 11, 2026, 17:16 PM -
REACTOGENICITY OF NUVAXOVID AND OTHER COMMERCIALIZED COVID-19 VACCINES: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL TO ESTIMATE THE HURLEY SCORE IN PATIENTS WITH HIDRADENITIS SUPPURATIVA
Aug 11, 2026, 17:16 PM -
CHARACTERIZING THE HUMANISTIC AND ECONOMIC BURDEN OF HYPOPHOSPHATASIA: A CROSS-SECTIONAL MULTINATIONAL STUDY IN CANADA, COLOMBIA, FRANCE, TURKEY AND THE UK
Aug 11, 2026, 17:16 PM -
NATIONAL BUDGET IMPACT ANALYSIS OF INTRODUCING COMBINED TRIPLE THERAPY (BUDESONIDE/ GLYCOPYRRONIUM/ FORMOTEROL FUMARATE) TO THE REIMBURSEMENT LIST FOR THE TREATMENT OF MODERATE-TO-SEVERE COPD IN ALGERIA
Aug 11, 2026, 17:16 PM -
EVALUATING AUTOMATED DEDUPLICATION: A PERFORMANCE COMPARISON OF EASYSLR AND ENDNOTE IN MULTI-DATABASE SYSTEMATIC LITERATURE REVIEWS
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF DIETARY HABITS AMONG WOMEN DIAGNOSED WITH ENDOMETRIOSIS
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY: A COMPARISON OF SPARSENTAN VERSUS IRBESARTAN AND MODIFIED-RELEASE BUDESONIDE IN SPAIN
Aug 11, 2026, 17:16 PM -
FRACTURE-RELATED COSTS OF HIGH-DOSE INTRAVENOUS IRON FORMULATION CHOICE: AUSTRIAN AND US REAL-WORLD EVIDENCE TRANSFERRED TO THE GERMAN HEALTHCARE SYSTEM
Aug 11, 2026, 17:16 PM -
REAL-WORLD PERSISTENCE AND SWITCHING PATTERNS AMONG FIRST-LINE AROMATASE INHIBITORS IN POSTMENOPAUSAL BREAST CANCER IN GREECE: EVIDENCE FROM THE NATIONAL E-PRESCRIPTION DATABASE (2020-2022)
Aug 11, 2026, 17:16 PM -
AN END-TO-END QUALITY ASSURANCE FRAMEWORK FOR REGULATORY-GRADE REAL-WORLD EVIDENCE FROM MULTI-SOURCE ELECTRONIC HEALTH RECORDS
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE BY EQ-5D-5L IN MULTIPLE SCLEROSIS: CHARACTERIZATION AND KEY ADVERSE FACTORS' DISUTILITIES
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC BURDEN OF HEMOLYTIC ANEMIA IN US PATIENTS WITH SICKLE CELL DISEASE: A REAL-WORLD ANALYSIS
Aug 11, 2026, 17:16 PM -
SLEEP QUALITY, NONPRESCRIBED SLEEP AID USE, AND MEDICATION SAFETY AWARENESS AMONG UNIVERSITY STUDENTS IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM
